News | Stethoscopes | November 15, 2016

Pilot Study Results Support Efficacy of eMurmur Computer-Aided Auscultation Platform

Software platform demonstrates high sensitivity and specificity in differentiating innocent versus pathologic pediatric heart murmurs

CSD Labs, eMurmur computer-aided auscultation software platform, pilot study, heart murmurs in children

November 15, 2016 — Computational Signal Detection (CSD) Laboratories LLC announced the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children.

According to the company, up to 90 percent of children will have a heart murmur at some point during their infancy or childhood. However, the majority of these heart murmurs detected in children will be clinically insignificant.

In this pilot study of 106 children at Children’s Hospital of Eastern Ontario, eMurmur differentiated pathologic from innocent heart murmurs with high sensitivity (87 percent) and specificity (100 percent), a positive predictive value of 100 percent, a negative predictive value of 90 percent, and high accuracy (94 percent) when compared with echocardiography as the gold standard for diagnosing murmurs.

CSD Labs has also clinically validated eMurmur as a tool for early and ongoing heart-health screening of teens, adults and elderly persons.

eMurmur is a software platform for the objective detection of heart murmurs that analyzes and classifies heart sounds acquired via an electronic stethoscope. The platform is comprised of an app that runs on a mobile device and is powered by SADIE, a Machine Intelligence Signal Analysis/Diagnosis Engine. Via Bluetooth or audio cable, the app pairs with any commercially available electronic stethoscope or other appropriate recording device, and receives and sends the acquired heart sounds to the HIPAA-compliant server for analysis. After a few seconds, the results are displayed to the healthcare professional on his/her mobile device where he/she can review, compare, consult or add his/her own findings in an efficient and standardized way.

CSD LABS CEO and Founder Andreas Schriefl, Ph.D., said eMurmur’s web portal offers medical professionals the capacity to retrieve a PDF report containing all results, and enables integration into electronic patient files and hospital information systems. Other benefits include e-consultation via the web portal (i.e., remote case reviewing by medical experts); and heart sound-monitoring by comparing current with previous auscultation data, including recordings and all findings.

For more information: www.csdlabs.com


Related Content

News | Stethoscopes

November 10, 2021 — eMurmur, a technology partner to the global healthcare community, announces the world’s first open ...

Home November 10, 2021
Home
Videos | Stethoscopes

Nelson B. Schiller, M.D., FACC, professor of medicine and the John J. Sampson and Lucy Stearn Endowed Chair of ...

Home July 16, 2021
Home
News | Stethoscopes

December 30, 2019 — Eko, a digital health company with an AI-powered cardiac screening platform, announced the second ...

Home December 30, 2019
Home
News | Stethoscopes

July 8, 2019 — Berkeley, Calif.-based digital health company Eko unveiled an investigational aortic stenosis (AS) ...

Home July 08, 2019
Home
News | Stethoscopes

October 26, 2018 — Eko, creators of a machine learning-based heart and lung monitoring platform, announced a ...

Home October 26, 2018
Home
Technology | Stethoscopes

March 22, 2016 — 3M Littmann Stethoscopes introduced the new Cardiology IV stethoscope, engineered to help clinicians ...

Home March 22, 2016
Home
Technology | Stethoscopes

November 19, 2015 — Rijuven announced the launch of CardioSleeve for Pediatrics, the first U.S. Food and Drug ...

Home November 19, 2015
Home
Technology | Stethoscopes

August 12, 2015 — 3M announced 12 new color options for its Littmann Classic III line of stethoscopes. The colors range ...

Home August 12, 2015
Home
Subscribe Now